EcoDrugPlus

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSEEEG00000001579
Gene Symbol: APEX1
4 Cross references
214 Possible Orthologues:

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSEEEG00000016557
Gene Symbol: APH1B
4 Cross references
186 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSEEEG00000015239
Gene Symbol: ABCC1
4 Cross references
203 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 8

Ensembl ID : ENSEEEG00000016308
Gene Symbol: ABCC8
1 Cross references
168 Possible Orthologues:

Atp-Binding Cassette, Sub-Family B (Mdr/tap), Member 5

Ensembl ID : ENSEEEG00000013867
Gene Symbol: ABCB5
3 Cross references
163 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSEEEG00000007434
Gene Symbol: ABCC8
4 Cross references
230 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 9

Ensembl ID : ENSEEEG00000003616
Gene Symbol: ABCC9
4 Cross references
233 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Alpha

Ensembl ID : ENSEEEG00000020022
Gene Symbol: ATP4A
4 Cross references
183 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSEEEG00000012470
Gene Symbol: ATP4B
4 Cross references
171 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1b

Ensembl ID : ENSEEEG00000019145
Gene Symbol: ATP1A1B
4 Cross references
255 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2a

Ensembl ID : ENSEEEG00000013951
Gene Symbol: ATP1A2A
2 Cross references
206 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1a

Ensembl ID : ENSEEEG00000005834
Gene Symbol: ATP1B1A
4 Cross references
152 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).